All posts by: Michael Zand

Aeglea BioTherapeutics to Present Preclinical Data at 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting – Markets Insider

Aeglea BioTherapeutics to Present Preclinical Data at 2017 Society for Immunotherapy of Cancer (SITC) Annual MeetingMarkets InsiderAUSTIN, Texas, Nov. 02, 2017 (GLOBE NEWSWIRE) — Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a biotechnology company comm… Continue reading

Bacteria in the Gut Modulates Response to Immunotherapy in Melanoma – Newswise (press release)

Bacteria in the Gut Modulates Response to Immunotherapy in MelanomaNewswise (press release)Newswise — HOUSTON – Bacteria that live in the human digestive tract can influence how cancer responds to immunotherapy, opening a new avenue for research to imp… Continue reading

Aeglea BioTherapeutics to Present Preclinical Data at 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting – GlobeNewswire (press release)

Aeglea BioTherapeutics to Present Preclinical Data at 2017 Society for Immunotherapy of Cancer (SITC) Annual MeetingGlobeNewswire (press release)AUSTIN, Texas, Nov. 02, 2017 (GLOBE NEWSWIRE) — Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a biotechnolog… Continue reading

A revolutionary gene-editing technology is on track to be a $10 billion market by 2025 – Business Insider

Researchers identify biomarkers for CAR T-cell therapy neurotoxicity – Healio

Researchers identify biomarkers for CAR T-cell therapy neurotoxicityHealioSerum biomarkers and early fever formed the basis of an algorithm that identified patients at increased risk for cytokine release syndrome and neurotoxicity following treatment w… Continue reading

Scientists figure out how stem cell therapy works in repairing cartilage – Horsetalk

HorsetalkScientists figure out how stem cell therapy works in repairing cartilageHorsetalkNew double-transgenic rodent models were used to identified the mode of action of stem cells. Photo: University of Veterinary Medicine, Vienna. Stem cell therapy … Continue reading